Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.
Dongxing ZhaoAsghar AbbasiHarry B RossiterXiaofen SuHeng LiuYuhong PiLi SangWeiyong ZhongQifeng YangXiongtian GuoYanyan ZhouTianyang LiRichard CasaburiNuofu ZhangPublished in: International journal of chronic obstructive pulmonary disease (2020)
In stable COPD patients, SAA was independently associated with the frequent exacerbator phenotype, suggesting that SAA may be a useful serum biomarker to inform progression or management in COPD.